The World Health Organization (WHO) defines pharmacovigilance as: “The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.” It monitors the safety of all medicines, aiming to prevent Adverse Drug Reactions (ADRs) and improve upon the effectiveness and safety of drugs through monitoring. Pharmacovigilance occurs on a local, national, and international level. Thanks to the WHO Programme for International Drug Monitoring, pharmacovigilance is improved by a global collaborative network. The network spans over 150 countries. Read on for more background on pharmacovigilance, why it matters, and the role of a.. READ MORE »
Do you want to start a promising career that allows you to help Canadians across the country stay safe and healthy? If you become a clinical trial and pharmacovigilance professional, you can do just that. Professionals in this field are responsible for the safety of drugs and medical devices. They also make sure that clinical trials are conducted safely and adhere to proper protocol. By ensuring that clinical trials run smoothly, pharmacovigilance professionals help expedite the process of getting life-changing pharmaceuticals to market. These pharmaceuticals can make a huge difference in the lives of people suffering from disease, illness, or.. READ MORE »
There are many openly available drugs on the market that, despite their health benefits, are known to sometimes have adverse effects on humans. Codeine, which is commonly found in both over the counter and prescription medications, is one of them. New research has shown that children are actually becoming more susceptible to the adverse effects of codeine. After several recent deaths due to codeine intoxication, pharmaceutical experts are now advising doctors and parents to stop providing children with medication that contains this seemingly harmless drug. If you’re planning to take a pharmaceutical drug safety course, or have already in enrolled,.. READ MORE »
